Publications
PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups: An International Multicenter Study
Ferdinandus, J,
Fendler, WP,
Farolfi, A,
Washington, S,
Mohamad, O,
Pampaloni, MH,
Scott, PJH,
Rodnick, M,
Viglianti, BL,
Eiber, M,
Herrmann, K,
Czernin, J,
Armstrong, WR,
Calais, J,
Hope, TA,
Piert, M,
J Nucl Med, 2022 Jan; DOI:10.2967/jnumed.121.262821 Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer
Xiao, L,
Parolia, A,
Qiao, Y,
Bawa, P,
Eyunni, S,
Mannan, R,
Carson, SE,
Chang, Y,
Wang, X,
Zhang, Y,
Vo, JN,
Kregel, S,
Simko, SA,
Delekta, AD,
Jaber, M,
Zheng, H,
Apel, IJ,
McMurry, L,
Su, F,
Wang, R,
Zelenka-Wang, S,
Sasmal, S,
Khare, L,
Mukherjee, S,
Abbineni, C,
Aithal, K,
Bhakta, MS,
Ghurye, J,
Cao, X,
Navone, NM,
Nesvizhskii, AI,
Mehra, R,
Vaishampayan, U,
Blanchette, M,
Wang, Y,
Samajdar, S,
Ramachandra, M,
Chinnaiyan, AM,
Nature, 2022 Jan; DOI:10.1038/s41586-021-04246-z Extrinsic KRAS signaling shapes the pancreatic microenvironment through fibroblast reprogramming.
Velez-Delgado, A,
Donahue, KL,
Brown, KL,
Du, W,
Irizarry-Negron, V,
Menjivar, RE,
Lasse Opsahl, EL,
Steele, NG,
The, S,
Lazarus, J,
Sirihorachai, VR,
Yan, W,
Kemp, SB,
Kerk, SA,
Bollampally, M,
Yang, S,
Scales, MK,
Avritt, FR,
Lima, F,
Lyssiotis, CA,
Rao, A,
Crawford, HC,
Bednar, F,
Frankel, TL,
Allen, BL,
Zhang, Y,
Pasca di Magliano, M,
Cell Mol Gastroenterol Hepatol, 2022 Jan; DOI:10.1016/j.jcmgh.2022.02.016 Factors Associated with Decision Aid Use in Localized Prostate Cancer
Lane, GI,
Dupati, A,
Qi, J,
Ferrante, S,
Dunn, RL,
Paudel, R,
Wittmann, D,
Wallner, L,
Berry, DL,
Ellimoottil, C,
Montie, J,
Clemens, JQ,
Urol Pract, 2022 Jan; DOI:10.1097/upj.0000000000000283 Phase i dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy
Gardner, SL,
Tarapore, RS,
Allen, J,
McGovern, SL,
Zaky, W,
Odia, Y,
Daghistani, D,
Diaz, Z,
Hall, MD,
Khatib, Z,
Koschmann, C,
Cantor, E,
Kurokawa, R,
MacDonald, TJ,
Aguilera, D,
Vitanza, NA,
Mueller, S,
Kline, C,
Lu, G,
Allen, JE,
Khatua, S,
Neurooncol Adv, 2022 Jan; DOI:10.1093/noajnl/vdac143 Molecular testing for melanocytic tumors: a practical update
Histopathology, 2022 Jan; DOI:10.1111/his.14570 Case report: Immune-mediated meibomian gland dysfunction following pembrolizumab therapy for advanced urothelial carcinoma
Nguyen, CB,
Su, CT,
Morgan, M,
Alva, AS,
Front Oncol, 2022 Jan; DOI:10.3389/fonc.2022.1000023 Melanoma developing in a nevoid melanocytoma with myxoid changes: a case report.
Kao, AS,
St Claire, K,
Bedford, LM,
Mehregan, DR,
Andea, AA,
Kouba, D,
Int J Clin Exp Pathol, 2022 Jan; Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Motzer, RJ,
Jonasch, E,
Agarwal, N,
Alva, A,
Baine, M,
Beckermann, K,
Carlo, MI,
Choueiri, TK,
Costello, BA,
Derweesh, IH,
Desai, A,
Ged, Y,
George, S,
Gore, JL,
Haas, N,
Hancock, SL,
Kapur, P,
Kyriakopoulos, C,
Lam, ET,
Lara, PN,
Lau, C,
Lewis, B,
Madoff, DC,
Manley, B,
Michaelson, MD,
Mortazavi, A,
Nandagopal, L,
Plimack, ER,
Ponsky, L,
Ramalingam, S,
Shuch, B,
Smith, ZL,
Sosman, J,
Dwyer, MA,
Gurski, LA,
Motter, A,
J Natl Compr Canc Netw, 2022 Jan; DOI:10.6004/jnccn.2022.0001 Changes in Serum, Red Blood Cell, and Colonic Fatty Acids in a Personalized Omega-3 Fatty Acid Supplementation Trial
Shen, Y,
Sen, A,
Turgeon, DK,
Ren, J,
Graifman, G,
Ruffin, MT,
Smith, WL,
Brenner, DE,
Djuric, Z,
Nutr Cancer, 2022 Jan; DOI:10.1080/01635581.2021.1903950 Major Changes in 2021 World Health Organization Classification of Central Nervous System Tumors.
Kurokawa, R,
Kurokawa, M,
Baba, A,
Ota, Y,
Pinarbasi, E,
Camelo-Piragua, S,
Capizzano, AA,
Liao, E,
Srinivasan, A,
Moritani, T,
Radiographics, 2022 Jan; DOI:10.1148/rg.210236 Association of MyProstateScore (MPS) with prostate cancer grade in the radical prostatectomy specimen
Eyrich, NW,
Wei, JT,
Niknafs, YS,
Siddiqui, J,
Ellimoottil, C,
Salami, SS,
Palapattu, GS,
Mehra, R,
Kunju, LP,
Tomlins, SA,
Chinnaiyan, AM,
Morgan, TM,
Tosoian, JJ,
Urol Oncol, 2022 Jan; DOI:10.1016/j.urolonc.2021.09.007 Transcranial Magnetic Resonance-Guided Histotripsy for Brain Surgery: Pre-clinical Investigation
Lu, N,
Gupta, D,
Daou, BJ,
Fox, A,
Choi, D,
Sukovich, JR,
Hall, TL,
Camelo-Piragua, S,
Chaudhary, N,
Snell, J,
Pandey, AS,
Noll, DC,
Xu, Z,
Ultrasound Med Biol, 2022 Jan; DOI:10.1016/j.ultrasmedbio.2021.09.008 Cell-Free Tumor DNA (cf-tDNA) Liquid Biopsy: Current Methods and Use in Brain Tumor Immunotherapy
Wadden, J,
Ravi, K,
John, V,
Babila, CM,
Koschmann, C,
Front Immunol, 2022 Jan; DOI:10.3389/fimmu.2022.882452 Embolization of Head Neck and spinal tumors
Siddiqui, F,
Rajah, G,
Gemmete, JJ,
Chaudhary, N,
Elias, A,
Pandey, AS,
2022 Jan; Sparse canonical correlation to identify breast cancer related genes regulated by copy number aberrations
Dutta, D,
Sen, A,
Satagopan, J,
PLoS One, 2022 Jan; DOI:10.1371/journal.pone.0276886 Receptor tyrosine kinase (RTK) targeting in pediatric high-grade glioma and diffuse midline glioma: Pre-clinical models and precision medicine
Schwark, K,
Messinger, D,
Cummings, JR,
Bradin, J,
Kawakibi, A,
Babila, CM,
Lyons, S,
Ji, S,
Cartaxo, RT,
Kong, S,
Cantor, E,
Koschmann, C,
Yadav, VN,
Front Oncol, 2022 Jan; DOI:10.3389/fonc.2022.922928 Comparative study of radiologists vs machine learning in differentiating biopsy-proven pseudoprogression and true progression in diffuse gliomas.
Turk, S,
Wang, NC,
Kitis, O,
Lee, J,
Mohammed, S,
Ma, T,
Lobo, R,
Kim, J,
Liao, E,
Camelo-Piragua, S,
Johnson, TM,
Kim, MM,
Junck, L,
Moritani, T,
Srinivasan, A,
Rao, A,
Bapuraj, JR,
Neuroscience Informatics, 2022 Jan; DOI:10.1016/j.neuri.2022.100088 Liquid biopsy in pediatric brain tumors
Tripathy, A,
John, V,
Wadden, J,
Kong, S,
Sharba, S,
Koschmann, C,
Front Genet, 2022 Jan; DOI:10.3389/fgene.2022.1114762 Comparison of Diagnostic Rates and Concordance with Subsequent Surgical Resections between Conventional Smear and ThinPrep Preparations versus ThinPrep Only in Thyroid Fine Needle Aspiration (T-FNA) Specimens
Rufail, M,
Jing, X,
Smola, B,
Heider, A,
Cantley, R,
Pang, JC,
Lew, M,
Acta Cytol, 2022 Jan; DOI:10.1159/000519489 Treatment related toxicities with combination BRAF and MEK inhibitor therapy in resected stage III melanoma
Homan, M,
Warrier, G,
Lao, CD,
Yentz, S,
Kraft, S,
Fecher, LA,
Front Oncol, 2022 Jan; DOI:10.3389/fonc.2022.855794 Eyelid and Periocular Cutaneous Carcinomas
Erickson, TR,
Heisel, CJ,
Bichakjian, CK,
Kahana, A,
2022 Jan; DOI:10.1007/978-3-030-42634-7_77 Liver injury during durvalumab-based immunotherapy is associated with poorer patient survival: A retrospective analysis
Swanson, LA,
Kassab, I,
Tsung, I,
Schneider, BJ,
Fontana, RJ,
Front Oncol, 2022 Jan; DOI:10.3389/fonc.2022.984940 Validation and Comparison of Radiograph-Based Organ Dose Reconstruction Approaches for Wilms Tumor Radiation Treatment Plans
Wang, Z,
Virgolin, M,
Balgobind, BV,
van Dijk, IWEM,
Smith, SA,
Howell, RM,
Mille, MM,
Lee, C,
Lee, C,
Ronckers, CM,
Bosman, PAN,
Bel, A,
Alderliesten, T,
Adv Radiat Oncol, 2022 Jan; DOI:10.1016/j.adro.2022.101015 Prevalence and determinants of oral and cervicogenital HPV infection: Baseline analysis of the Michigan HPV and Oropharyngeal Cancer (MHOC) cohort study
Brouwer, AF,
Campredon, LP,
Walline, HM,
Marinelli, BM,
Goudsmit, CM,
Thomas, TB,
Delinger, RL,
Lau, YK,
Andrus, EC,
Yost, ML,
McCloskey, JK,
Sullivan, TS,
Mortensen, AS,
Huang, S,
Murphy, K,
Cheng, B,
Stanek, K,
Nair, T,
Carey, TE,
Meza, R,
Eisenberg, MC,
PLoS One, 2022 Jan; DOI:10.1371/journal.pone.0268104 